Total Funding
$35M
Employee Range
11-50
Synklino develops an immunotoxin targeting cytomegalovirus, aiming to eliminate the infection.
Synklino data powered by:
Share
Synklino data powered by:
SynklinoOverall Ranking
Regional Rank
Share
Loading...
In Western Europe
Top null%out of startups
SynklinoIndustry Rankings in
Healthtech
City Rank
Share
4th
In Lyngby
Top 50%out of 8 startups
National Rank
Share
40th
In Denmark
Top 28%out of 147 startups
Regional Rank
Share
1,224th
In Western Europe
Top 29%out of 4369 startups
SynklinoSubindustry Rankings in
BiotechnologyCity Rank
Share
3rd
In Lyngby
Top 75%out of 4 startups
National Rank
Share
28th
In Denmark
Top 36%out of 78 startups
Regional Rank
Share
536th
In Western Europe
Top 31%out of 1765 startups
rankings by:
SynklinoSB Rank Evolution
Not enough data points to display the chart.
SynklinostartupComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro